Home / Health / Scientists Partially Reverse Cellular Aging in Humans
Scientists Partially Reverse Cellular Aging in Humans
25 Jun
Summary
- First human participant treated in a clinical trial for cellular reprogramming.
- The experimental therapy targets glaucoma and optic nerve damage.
- Researchers activate three genes to make older cells function like younger ones.
A significant step toward testing the concept of reversing aging in humans is underway, with the first participant treated in a clinical trial. This early-stage study, conducted by Life Biosciences, is investigating whether older cells can be partially reprogrammed to exhibit younger characteristics.
The primary focus of this trial is not lifespan extension but the treatment of glaucoma, an eye condition that damages the optic nerve and can lead to blindness. Researchers aim to regenerate these damaged neurons, which typically do not regrow once affected.
The therapy employs partial cellular reprogramming, a technique involving the activation of three specific genes within older cells. This process nudges the cells toward a younger biological state while preserving their essential functions. Animal studies have shown promise in restoring youthful tissue function, sparking hope for nerve recovery.
Despite the excitement, scientists emphasize that the technology is highly experimental and carries risks, including the potential for cancerous cell alterations. While animal trials have yielded encouraging results, human testing is just beginning.
